Literature DB >> 22524801

Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents.

Edy Meiyanto1, Adam Hermawan.   

Abstract

Targeted therapy has been a very promising strategy of drug development research. Many molecular mechanims of diseases have been known to be regulated by abundance of proteins, such as receptors and hormones. Chemoprevention for treatment and prevention of diseases are continuously developed. Pre-clinical and clinical studies in chemoprevention field yielded many valuable data in preventing the onset of disease and suppressing the progress of their growth, making chemoprevention a challenging and a very rational strategy in future researches. Natural products being rich of flavonoids are those fruits belong to the genus citrus. Ethanolic extract of Citrus reticulata and Citrus aurantiifolia peels showed anticarcinogenic, antiproliferative, co-chemotherapeutic and estrogenic effects. Several examples of citrus flavonoids that are potential as chemotherapeutic agents are tangeretin, nobiletin, hesperetin, hesperidin, naringenin, and naringin. Those flavonoids have been shown to possess inhibition activity on certain cancer cells' growth through various mechanisms. Moreover, citrus flavonoids also perform promising effect in combination with several chemotherapeutic agents against the growth of cancer cells. Some mechanisms involved in those activities are through cell cycle modulation, antiangiogenic effect, and apoptosis induction. Previous studies showed that tangeretin suppressed the growth of T47D breast cancer cells by inhibiting ERK phosphorylation. While in combination with tamoxifen, doxorubicin, and 5-FU, respectively, it was proven to be synergist on several cancer cells. Hesperidin and naringenin increased cytotoxicitity of doxorubicin on MCF-7 cells and HeLa cells. Besides, citrus flavonoids also performed estrogenic effect in vivo. One example is hesperidin having the ability to decrease the concentration of serum and hepatic lipid and reduce osteoporosis of ovariectomized rats. Those studies showed the great potential of citrus fruits as natural product to be developed as not only the source of co-chemotherapeutic agents, but also phyto-estrogens. Therefore, further study needs to be conducted to explore the potential of citrus fruits in overcoming cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524801     DOI: 10.7314/apjcp.2012.13.2.427

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  52 in total

1.  Naringenin modulates skeletal muscle differentiation via estrogen receptor α and β signal pathway regulation.

Authors:  Marco Pellegrini; Pamela Bulzomi; Paola Galluzzo; Marco Lecis; Stefano Leone; Valentina Pallottini; Maria Marino
Journal:  Genes Nutr       Date:  2014-08-26       Impact factor: 5.523

2.  Design, synthesis and experimental validation of novel potential chemopreventive agents using random forest and support vector machine binary classifiers.

Authors:  Brienne Sprague; Qian Shi; Marlene T Kim; Liying Zhang; Alexander Sedykh; Eiichiro Ichiishi; Harukuni Tokuda; Kuo-Hsiung Lee; Hao Zhu
Journal:  J Comput Aided Mol Des       Date:  2014-05-20       Impact factor: 3.686

3.  Preclinical evaluation of the supercritical extract of azadirachta indica (neem) leaves in vitro and in vivo on inhibition of prostate cancer tumor growth.

Authors:  Qiang Wu; Manish Kohli; H Robert Bergen; John C Cheville; R Jeffrey Karnes; Hong Cao; Charles Y F Young; Donald J Tindall; Mark A McNiven; Krishna Vanaja Donkena
Journal:  Mol Cancer Ther       Date:  2014-03-27       Impact factor: 6.261

4.  Analysis of biologically active oxyprenylated ferulic acid derivatives in Citrus fruits.

Authors:  Salvatore Genovese; Serena Fiorito; Marcello Locatelli; Giuseppe Carlucci; Francesco Epifano
Journal:  Plant Foods Hum Nutr       Date:  2014-09       Impact factor: 3.921

5.  Molecular mechanisms underlying the α-tomatine-directed apoptosis in human malignant glioblastoma cell lines A172 and U-118 MG.

Authors:  Fa-Zhao Wang; Xue-Liang Dai; Hong-Yi Liu
Journal:  Exp Ther Med       Date:  2017-10-12       Impact factor: 2.447

6.  Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells.

Authors:  Zeynep Birsu Cincin; Miray Unlu; Bayram Kiran; Elif Sinem Bireller; Yusuf Baran; Bedia Cakmakoglu
Journal:  Cell Oncol (Dordr)       Date:  2015-04-10       Impact factor: 6.730

7.  Fisetin suppresses ADAM9 expression and inhibits invasion of glioma cancer cells through increased phosphorylation of ERK1/2.

Authors:  Chien-Min Chen; Yi-Hsien Hsieh; Jin-Ming Hwang; Hsun-Jin Jan; Shu-Ching Hsieh; Shin-Huey Lin; Chung-Yu Lai
Journal:  Tumour Biol       Date:  2014-12-20

8.  Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway.

Authors:  Lei Bao; Feng Liu; Huai-Bin Guo; Yong Li; Bi-Bo Tan; Wan-Xing Zhang; Yan-Hui Peng
Journal:  Tumour Biol       Date:  2016-03-10

9.  In vitro study on reversal of ovarian cancer cell resistance to cisplatin by naringin via the nuclear factor-κB signaling pathway.

Authors:  Hong Zhu; Jun Gao; Lei Wang; Ke-Jian Qian; Li-Ping Cai
Journal:  Exp Ther Med       Date:  2018-01-04       Impact factor: 2.447

10.  Naringenin: a partial agonist on estrogen receptor in T47D-KBluc breast cancer cells.

Authors:  Sunzoo Kim; Tae In Park
Journal:  Int J Clin Exp Med       Date:  2013-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.